FMO5 and triple-A syndrome: We next studied effects of chelerythrine on NADPH-stimulated oxidase activity in AAA aortas, but similarly to basal O2•− production we found no effect of PKC inhibition on NADPH oxidase activity in AAA (Fig. 3C).